|October 28, 2002|
Taisho Launches Taisho Ichou Oral Solution
Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) announces the November 4 launch of a "Taisho Ichou Oral Solution" (50 mL 350 yen), a gastrointestinal drink with refreshing crisp taste.
"Taisho Ichou Oral Solution" is combined with "carnitine chloride" which activates stomach functions additionally with "stomach nature remedies" which help gastrointestinal actions. It is a drink-type quasi-drug for epigastric discomfort, retching and queasiness from excessive eating or excessive drinking. This is our first sale of a gastrointestinal drink (quasi-drug) and will reinforce the line-up of goods directed to food related channels of convenience stores and the like following Lipovitan D, ALFE-Mini, etc.
According to the research of our company, the gastrointestinal drink market of quasi drugs shows the increasing rate of 170% compared to the last year. It suggests that convenience of consumers purchasing in convenience stores and the like is supported. In addition, tendency of purchasing gastrointestinal drinks will reach its peak in December and January, the market being about one and half times as big as that in ordinary months, coming to the stage from now.
The line-up of gastrointestinal drugs in our company includes a Chinese herbal gastrointestinal drug group including "Taisho Kampo Ichoyaku" put on the market in 1978 followed by "Taisho Chuyaku Ichoyaku" which is a Chinese herbal prescription, and a drink-type "Taisho Kampo Ichoyaku<Oral Solution>", "Avalon Z" with a H2 blocker, "Avalon S" with a restoring agent of gastric mucosa, all being on the market.